Overview

Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to assess the effect of renal impairment on the pharmacokinetics, safety and tolerability of udenafil in subjects with renal impairment compared to healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Asan Medical Center
Collaborator:
Dong-A Pharmaceutical Co., Ltd.
Treatments:
Udenafil